Cargando…
Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma
Adriamycin-based chemotherapy is commonly used for malignant soft tissue sarcoma including myxoid liposarcoma. However, in the case of unavailability or failure of the adriamycin-based regimen, trabectedin or eribulin can produce a good antitumor effect for myxoid liposarcoma. We relate the experien...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683141/ https://www.ncbi.nlm.nih.gov/pubmed/33274094 http://dx.doi.org/10.1155/2020/8873185 |